Epidemiology, Impact, and Management Strategies of Anti-Glomerular Basement Membrane Disease
Muhammad Asim,Mohammed Akhtar
DOI: https://doi.org/10.2147/IJNRD.S326427
2022-04-08
International Journal of Nephrology and Renovascular Disease
Abstract:Muhammad Asim, 1 Mohammed Akhtar 2 1 Division of Nephrology, Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; 2 Department of Laboratory Medicine and Pathology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar Correspondence: Muhammad Asim, Division of Nephrology, Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, Tel +97455838342, Email Anti-glomerular basement membrane (anti-GBM) disease is a rare but serious autoimmune disease, which is characterized by the development of pathogenic antibodies to type IV collagen antigens in the glomerular and alveolar basement membranes. This results in rapidly progressive glomerulonephritis (GN), alveolar hemorrhage, or both. A variety of environmental factors can trigger the disease in genetically predisposed patients. Temporal associations with influenza, SARS-CoV-2 infection, and COVID-19 vaccination have been described although there is insufficient evidence to suggest causality. Anti-GBM disease accounts for approximately 20% of the cases of rapidly progressive GN cases secondary to crescentic GN, but is an uncommon cause of end-stage kidney disease. Early diagnosis by detection of circulating antibodies, increased awareness of atypical as well as complex clinical variants of the disease, and combined therapy with immunosuppression and plasma exchange has improved the prognosis of patients with this potentially fatal disease. Progress has been hampered by the rarity of anti-GBM disease, but new agents and therapeutic regimens are emerging. Keywords: antibody, glomerulonephritis, rapidly progressive glomerulonephritis, plasma exchange, IdeS, rituximab Anti-glomerular basement membrane (anti-GBM) disease is an autoimmune small- vessel vasculitis caused by immunoglobulin (Ig) G autoantibodies that are mainly directed against the non-collagenous domain of the α3 chain of type IV collagen in the glomerular basement membrane. 1 These antibodies typically cause a rapidly progressive GN, often combined with pulmonary hemorrhage because the autoantibodies react with the same epitope in the alveolar basement membrane. 2 The basement membranes in the glomerular and pulmonary alveolar capillaries are complex structures lined by endothelial and epithelial cells. The principal component of the basement membrane is type IV collagen (Figure 1), which includes three alpha subunits: alpha3, alpha4 and alpha5 chains (Figure 1A). Each chain comprises a long collagenous domain, a non-collagenous amino terminus (7S), and a non-collagenous domain (NC1) at the carboxyl terminus. NC1 domains of the alpha3, alpha4 and alpha5 chains join to form an extensively crosslinked helical molecule known as a protomer (Figure 1B). 1,3 The protomers dimerize at NC1 domains to form hexamers, that further interconnect to form a collagenous meshwork. Deposition of additional proteins such as agrin, laminin, and nidogen completes the formation of the basement membrane. 4 The anti-GBM antibodies are most strongly reactive to alpha3 (IV) NC1, although there may also be variable reactivity to alpha5 (IV) NC1 and a lesser extent, alpha4 (IV) NC1. 1,5 The autoantibodies bind to two epitopes, designated EA and EB, located at the amino acid residues 17–31 and 127–141 respectively, in the NC1 domain of alpha3 (IV) (Figure1C). 6 These epitopes are partly buried and hidden during the assembly of hexamers. Figure 1 ( A ) Cartoon showing alpha3, alpha4 and alpha5 chains of type IV collagen. Each chain consists of collagenous component in the middle with non-collagenous domains (7S and NC1) at the ends. ( B ) NC1 domains of the alpha3, alpha4 and alpha5 chains join to form a triple helical extensively crosslinked molecule known as protomer. The protomers dimerize at NC1 domains to form alpha3.alpha4.alpha5 (IV)NC1 hexamers. ( C ) Cartoon depicting NC1 domain of the alpha3 chain of type IV collagen with two epitopes, namely EA (residues 17–31) and EB (residues 127–141). Copyright © 2022 Mohammed Akhtar, Corel Corporation and its licensors. All rights reserved. Immunofluorescent microscopy demonstrates characteristic intense and diffuse linear IgG deposition along the glomerular basement membrane (Figure 2). On light microscopy the glomeruli characteristically display segmental or global necrosis, and rupture of the capillary tufts, associated with prominent crescent formation in most of the cases (Figure 3). 7,8 The glomerular changes are temporally homogeneous, with all glomeruli presenting the same stage of the disease process. Other findings usually include intratubular red cells, interstitial edema, and interstitial inflammatory infiltrate composed -Abstract Truncated-